Zai Lab (ZLAB) News Today

$19.40
-0.53 (-2.66%)
(As of 05/17/2024 ET)
Frazor Titus Edmondson III Sells 10,000 Shares of Zai Lab Limited (NASDAQ:ZLAB) Stock
Zai Lab Limited (NASDAQ:ZLAB - Get Free Report) insider Frazor Titus Edmondson III sold 10,000 shares of Zai Lab stock in a transaction that occurred on Tuesday, May 14th. The shares were sold at an average price of $21.33, for a total value of $213,300.00. Following the completion of the transaction, the insider now owns 16,408 shares of the company's stock, valued at $349,982.64. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Zai Lab (NASDAQ:ZLAB) Shares Gap Down to $20.85
Zai Lab (NASDAQ:ZLAB) Shares Gap Down to $20.85
Zai Lab (NASDAQ:ZLAB) Trading Up 9.7%
Zai Lab (NASDAQ:ZLAB) Shares Up 9.7%
China Approves Zai Lab's AUGTYRO For ROS1-Positive NSCLC Treatment
Zai Lab (NASDAQ:ZLAB) Shares Gap Down to $21.01
Segantii Capital Management Ltd Sells 101,430 Shares of Zai Lab Limited (NASDAQ:ZLAB)
Segantii Capital Management Ltd trimmed its holdings in Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 5.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,687,569 shares of the company's stock a
Zai Lab (NASDAQ:ZLAB) Releases Earnings Results, Beats Estimates By $0.38 EPS
Zai Lab (NASDAQ:ZLAB - Get Free Report) issued its quarterly earnings data on Wednesday. The company reported ($0.55) earnings per share for the quarter, topping analysts' consensus estimates of ($0.93) by $0.38. The firm had revenue of $87.15 million for the quarter, compared to analyst estimates of $77.07 million. Zai Lab had a negative return on equity of 37.07% and a negative net margin of 125.46%. During the same period last year, the company earned ($0.51) EPS.
Zai Lab (NASDAQ:ZLAB) Shares Gap Up After Earnings Beat
Zai Lab (NASDAQ:ZLAB) Shares Gap Up Following Earnings Beat
Here's what Wall Street expects from Zai Lab's earnings report
Here's what Wall Street expects from Zai Lab's earnings
Zai Lab (NASDAQ:ZLAB) Shares Gap Up to $15.90
Zai Lab (NASDAQ:ZLAB) Shares Gap Up to $15.90
Zai Lab Limited's (NASDAQ:ZLAB) Profit Outlook
Vivo Capital LLC Acquires 119,521 Shares of Zai Lab Limited (NASDAQ:ZLAB)
Vivo Capital LLC lifted its holdings in shares of Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 29.0% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 531,198 shares of the company's stoc
Zai Lab Limited Forecasted to Post FY2024 Earnings of ($3.50) Per Share (NASDAQ:ZLAB)
Zai Lab Limited (NASDAQ:ZLAB - Free Report) - Research analysts at Cantor Fitzgerald increased their FY2024 earnings estimates for shares of Zai Lab in a report released on Tuesday, April 23rd. Cantor Fitzgerald analyst L. Chen now anticipates that the company will post earnings per share of ($3.
Zai Lab (NASDAQ:ZLAB) Shares Up 5.3%
Zai Lab (NASDAQ:ZLAB) Shares Up 5.3%
Zai Lab (NASDAQ:ZLAB) Shares Gap Up to $14.07
Zai Lab (NASDAQ:ZLAB) Shares Gap Up to $14.07
Zai Lab Ltd. ADR
Zai Lab Limited (ZLAB)
Zai Lab (NASDAQ:ZLAB) Shares Down 2.4%
Zai Lab (NASDAQ:ZLAB) Trading Down 2.4%
Genesis Investment Management LLP Sells 339,503 Shares of Zai Lab Limited (NASDAQ:ZLAB)
Genesis Investment Management LLP trimmed its holdings in Zai Lab Limited (NASDAQ:ZLAB - Free Report) by 32.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 692,663 shares of the company's stock after selling 339,503
A Risky Bet: Zai Lab's Uncertain Future
Zai Lab (NASDAQ:ZLAB) Sets New 52-Week Low at $14.01
Zai Lab (NASDAQ:ZLAB) Sets New 1-Year Low at $14.01
Zai Lab (NASDAQ:ZLAB) Reaches New 52-Week Low at $15.13
Zai Lab (NASDAQ:ZLAB) Sets New 12-Month Low at $15.13
Zai Lab (NASDAQ:ZLAB) Shares Gap Up to $15.49
Zai Lab (NASDAQ:ZLAB) Shares Gap Up to $15.49
Zai Lab Limited (NASDAQ:ZLAB) Insider Sells $14,292.75 in Stock
Zai Lab Limited (NASDAQ:ZLAB - Get Free Report) insider Frazor Titus Edmondson III sold 885 shares of the company's stock in a transaction dated Tuesday, April 2nd. The stock was sold at an average price of $16.15, for a total transaction of $14,292.75. Following the completion of the sale, the insider now directly owns 22,621 shares of the company's stock, valued at approximately $365,329.15. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
Zai Lab (NASDAQ:ZLAB) Sets New 12-Month Low at $15.53
Zai Lab (NASDAQ:ZLAB) Sets New 1-Year Low at $15.53
Get Zai Lab News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZLAB and its competitors with MarketBeat's FREE daily newsletter.

get a piece of the profit from this land (Ad)

This isn’t the prettiest land on earth. But it might be the most valuable. And you don’t have to own, lease, or rent any land.

Click here to see my #1 investment for 2024.

ZLAB Media Mentions By Week

ZLAB Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ZLAB
News Sentiment

0.59

0.42

Average
Medical
News Sentiment

ZLAB News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ZLAB Articles
This Week

15

4

ZLAB Articles
Average Week

Get Zai Lab News Delivered to You Automatically

Sign up to receive the latest news and ratings for ZLAB and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:ZLAB) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners